Senzime AB (FRA:6YC) Accounts Payable: €0.42 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6YC Senzime AB FRA:6YC
71 GF Score
Price €0.32
GF Value €0.70
! 3 Warning Signs
View Full Analysis

What is Senzime AB Accounts Payable?

Senzime AB FRA:6YC -8.13% 71 Accounts Payable is €0.42 Mil as of Jun. 2026. GuruFocus rates FRA:6YC with a GF Score™ of 71/100 and a GF Value™ of €0.70. The stock has 3 warning signs investors should review.

Senzime AB's Accounts Payable for the quarter that ended in Jun. 2026 was €0.42 Mil.

Senzime AB's quarterly Accounts Payable declined from Dec. 2025 (€0.88 Mil) to Mar. 2026 (€0.78 Mil) and declined from Mar. 2026 (€0.78 Mil) to Jun. 2026 (€0.42 Mil).

Senzime AB's annual Accounts Payable increased from Dec. 2023 (€0.46 Mil) to Dec. 2024 (€0.77 Mil) and increased from Dec. 2024 (€0.77 Mil) to Dec. 2025 (€0.88 Mil).

Senzime AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Senzime AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senzime AB Accounts Payable Chart

Senzime AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.67 0.46 0.77 0.88

Senzime AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.82 0.88 0.78 0.42
FRA:6YC
71GF Score
Senzime AB FRA:6YC
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senzime AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.42 Mil mean?
Senzime AB (FRA:6YC) has a Accounts Payable of €0.42 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Senzime AB and its competitors.
Is Senzime AB's Accounts Payable too high?
Senzime AB's current Accounts Payable is €0.42 Mil. Overall, Senzime AB has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Senzime AB's Accounts Payable compare to ABT and SYK?
Senzime AB's Accounts Payable of €0.42 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Senzime AB and its competitors. Senzime AB's current Accounts Payable is €0.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senzime AB stock overvalued right now?
Senzime AB (FRA:6YC) has a current Accounts Payable of €0.42 Mil. The stock's GF Value™ is €0.70, compared to a current price of €0.32 — trading 54.8% below its estimated fair value. The current Accounts Payable is €0.42 Mil. Senzime AB's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Senzime AB (FRA:6YC), the current Accounts Payable is €0.42 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Senzime AB (FRA:6YC) Overvalued in 2026?

Based on GuruFocus' analysis, Senzime AB stock appears to be undervalued. The current stock price of €0.32 is trading 54.8% below its estimated GF Value™ of €0.70.

Key valuation signals for FRA:6YC:

  • Accounts Payable: €0.42 Mil
  • GF Value™: €0.70 vs. price of €0.32 (54.8% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the FRA:6YC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Senzime AB Business Description

Other Exchanges SNZZF:USASEZI:Sweden
Address Verkstadsgatan 8, hus 1, Uppsala, SWE, 753 23
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
71GF Score

Get the complete analysis for FRA:6YC

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.32
Price
€0.70
GF Value